Jiashu Xie

839 citations
48 papers · 658 indexed · h-index 17
Topics
HIV/AIDS drug development and treatment (16 papers)HIV Research and Treatment (14 papers)Hepatitis C virus research (8 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Jiashu Xie

45 papers receiving 652 citations

Peers

Jiashu Xie
Comparison fields: 5 of 75
  • Molecular Biology 289
  • Infectious Diseases 230
  • Virology 140
  • Epidemiology 120
  • Organic Chemistry 97
Replace Judy S. Mathew with:
Judy S. Mathew United States
Paula M. Brito Portugal
Dabo Pan China
Erica S. Lovelace United States
Fisayo A. Olotu South Africa
Asim Azhar Siddiqui India
Sheng Tang China
Biehuoy Shieh United States
Alcides J. M. da Silva Brazil
Giuliana Cuzzucoli Crucitti Italy
Jiashu Xie relative to Judy S. Mathew United States Judy S. Mathew's profile →
Citations per field
00.5×10×20×32×
Judy S. Mathew · 1×
Citations per year

Countries citing papers authored by Jiashu Xie

Since Specialization
Citations

This map shows the geographic impact of Jiashu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiashu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiashu Xie more than expected).

Fields of papers citing papers by Jiashu Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiashu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiashu Xie. The network helps show where Jiashu Xie may publish in the future.

Co-authorship network of co-authors of Jiashu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Jiashu Xie. A scholar is included among the top collaborators of Jiashu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiashu Xie. Jiashu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 23
4 4
5 19
6 7
7 6
8 19
9 19
10 15
11 17
12 27
13 23
14 12
15 11
16 12
17 14
18 10
19 8
20 24

About Jiashu Xie

Jiashu Xie is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 48 papers that have together received 658 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (14 papers) and Hepatitis C virus research (8 papers). The work is most often cited by research in Virology (140 citations), Infectious Diseases (230 citations) and Hepatology (62 citations). Jiashu Xie has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Zhengqiang Wang, Jayakanth Kankanala, Stefan G. Sarafianos, Daniel J. Wilson, Liqiang Chen, Swati S. More, Mary C. Casey, Karen A. Kirby, Lei Wang and Huanchun Zhang. Their work appears in journals such as Cancer Research, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026